MOG-IgG-associated disease has a stereotypical clinical course, asymptomatic visual impairment and good treatment response
Objectives We investigated the clinical characteristics and treatment response in myelin oligodendrocyte glycoprotein antibody (MOG-IgG)-associated disease and looked for evidence of subclinical disease. Methods We prospectively evaluated the frequency and pattern of relapse, tested afferent visual...
Gespeichert in:
Veröffentlicht in: | Multiple sclerosis journal - experimental, translational and clinical translational and clinical, 2018-07, Vol.4 (3), p.2055217318787829-2055217318787829 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Objectives
We investigated the clinical characteristics and treatment response in myelin oligodendrocyte glycoprotein antibody (MOG-IgG)-associated disease and looked for evidence of subclinical disease.
Methods
We prospectively evaluated the frequency and pattern of relapse, tested afferent visual function and monitored treatment response in 42 south Asian patients from a single centre.
Results
Eighteen patients (42.9%) had monophasic and 24 (57.1%) a relapsing course. Disease duration was longer (P |
---|---|
ISSN: | 2055-2173 2055-2173 |
DOI: | 10.1177/2055217318787829 |